FlavoLife is committed to
developing innovative, highly effective,
and safe senolytic products
Pioneering research in Aging Science and Therapeutics
FlavoLife was founded by a dedicated team of leading scientists and visionary entrepreneurs, united by a shared passion for the science of aging and a commitment to developing senolytic therapeutics that empower people to live longer, healthier lives.
By blending their expertise and insights, they have created a dynamic hub of innovation, driving groundbreaking advancements in the field.
Bridging Innovation and Strategy for Breakthrough Drug Development
Our team excels at seamlessly connecting commercial vision with R&D expertise, ensuring that every step of drug development aligns with market needs and scientific innovation.
In a world where countless age-related diseases demand attention, we focus on identifying the most impactful opportunities.
By strategically prioritizing research areas, we channel our efforts to develop superior senolytic products that address the diseases where senescent cells play a significant pathogenic role.
With this approach, we don’t just create solutions, we pave the way for a healthier future.
Meet our Team
Paolo Correale
CEO
Paolo has worked for over 15 years in the management consulting sector, holding the positions of Senior Principal at EVERSANA. He has successfully led the development and execution of numerous global launches of pharmaceutical products and medical devices.
Giovanni Mario Pitari
Medical Innovation Officer
Mario Correale
Clinical Officer
He served as the Director of the Clinical Pathology & Research laboratories at IRCCS De Bellis Castellana Grotte (BA). With over thirty years of experience in the field of biomarkers, he has authored numerous publications in leading scientific journals. His expertise also includes clinical experimentation, where he has successfully contributed to the design and execution of clinical studies.
Alessandro Aronica
Business Development
Alessandro has over 9 years of experience in management consulting, specializing in the pharmaceutical sector. He has worked with both global industry leaders and SMEs/Family Businesses, helping them drive commercial growth, launch new products, conduct technological due diligence, and achieve operational excellence.